As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge

For now, Eli Lilly’s orforglipron appears to be the top contender in the weight loss pill space due to its strong efficacy data and ease of use.

Related Keywords

United States ,Denmark ,San Diego ,California ,America ,Danish ,Geoff Meacham ,Eduardo Grunvald ,Cantor Fitzgerald Chen ,Eli Lilly ,Mohit Bansal ,John Yoon ,Louise Chen ,Uc Davis Health ,Cantor Fitzgerald ,Pfizer ,Wells Fargo ,Drug Administration ,Novo Nordisk ,Uc San Diego Center ,Advanced Weight ,Pharmaceuticals ,